Healthcare-Associated Infections (IDSA Bundle)

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, Enjoy!

Issue link:

Contents of this Issue


Page 9 of 9

Strength of Recommendation and Quality of Evidence Category/Grade Definition Strength of Recommendation A Good evidence to support a recommendation for or against use. B Moderate evidence to support a recommendation for or against use. C Poor evidence to support a recommendation. Quality of Evidence I Evidence from ≥ 1 properly randomized, controlled trial. II Evidence from ≥ 1 well-designed clinical trial, without randomization; from cohort or case-controlled analytic studies (preferably from > 1 center); from multiple time-series; or from dramatic results from uncontrolled experiments. III Evidence from opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees. Source Yokoe DS, Mermel LA, Anderson DA, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(Suppl 1):S12-S21 Abbreviations CAUTI, catheter-associated urinary tract infection; CDI, Clostridium difficile infection; CLABSI, central line-associated bloodstream infection; ICU, intensive care unit; MRSA, methicillin-resistant Staphylococcus aureus; SSI, surgical site infection; VAP, ventilatorassociated pneumonia Disclaimer This Guideline attempts to define principles of practice that should produce high-quality patient care. It focuses on the needs of primary care practice but also is applicable to providers at all levels. This Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. The ultimate judgment concerning the propriety of any course of conduct must be made by the clinician after consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. HAI081113 5740 Executive Drive  Suite 218 Baltimore, MD 21228  TEL: 410-869-3332  •  FAX: 410-744-2150  For additional copies: Copyright © 2011 All rights reserved

Articles in this issue

Links on this page

Archives of this issue

view archives of IDSA GUIDELINES Bundle - Healthcare-Associated Infections (IDSA Bundle)